Patel Chintu - 02 Mar 2026 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Co-CEO, Director
Signature: /s/ Denis Butkovic, Attorney-in-Fact
Issuer symbol: AMRX
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2026, 16:29:43 UTC
Previous filing: 05 Mar 2025
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Patel Chintu	Co-CEO, Director	C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER	/s/ Denis Butkovic, Attorney-in-Fact	03 Mar 2026	0001737428

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMRX	Restricted Stock Units	Award	$0	+190,632		$0.000000	190,632	02 Mar 2026	Class A Common Stock	190,632		Direct	F1, F2
transaction	AMRX	Performance-Based Restricted Stock Units	Award	$0	+354,031		$0.000000	354,031	02 Mar 2026	Class A Common Stock	354,031		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2	The restricted stock units vest in four equal annual installments beginning on March 2, 2027.
F3	Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F4	Represents a performance-based restricted stock unit grant of 354,031 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period.